相关实验视频

Updated: May 16, 2025

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

在TIL表达可调节的膜结合IL-15的IL-2独立扩张,持久性和抗瘤活性

Rachel A Burga¹, Bulent Arman Aksoy¹, Zheng Ao¹

¹Research and Development, Obsidian Therapeutics, Cambridge, MA, USA.

Molecular therapy : the journal of the American Society of Gene Therapy

|April 26, 2025

概括

使用膜结合的互白素-15 (mbIL15) 工程化瘤透淋巴细胞 (TIL) 提供了无互白素-2 (IL-2) 的采用细胞疗法. 这种新的方法增强了T细胞的活性和持久性,可能提高黑色素瘤患者的安全性.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

使用瘤透性淋巴细胞 (TIL) 的采用细胞疗法在转移性黑色素瘤中显示出有前途.
互乐金-2 (IL-2) 的同时使用是必要的,但会带来安全风险,并限制患者的适用性.

研究的目的:

为了评估工程TIL的有效性和安全性,用膜结合的互白素-15 (mbIL15) 作为一种无IL-2的替代品.
评估工程TIL扩张和活动的药物诱导调节.

主要方法:

TIL被设计为表达mbIL15与药物反应域 (DRD) 融合,产生cytoTIL15细胞.
用乙醇胺 (ACZ) 而不是IL-2制造的cytoTIL15细胞.
在体外和体内研究,包括患者衍生异种移植 (PDX) 模型,用于评估扩张,持久性和抗瘤活性.

主要成果:

cytoTIL15细胞在体外和体内表现出了剂量依赖的ACZ扩张和持久性.
在没有IL-2的人类黑色素瘤模型中,cytoTIL15细胞表现出强大的瘤杀伤活性.
在PDX模型中的空间分析显示,cytoTIL15细胞具有高度的细胞毒性,并且比非工程TIL更少耗尽.

结论:

工程TIL与mbIL15提供了一个无IL-2的采用细胞治疗平台.
这种方法有可能提高耐受性和安全性,并通过对TIL活性进行药理学控制.
cytoTIL15细胞代表了耐火性黑色素瘤治疗的有前途的进步.

关键词:

在TIL TIL.采用细胞疗法采用细胞疗法降级 degron 降级降低降低药物反应的领域是药物反应的领域.膜结合的互乐金-15 监管监管监管监管监管监管合成生物学合成生物学透到瘤中的淋巴细胞

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...